RTT News
RTT News
... closed Monday's regular trading session at $32.60, up 26 cents and gained an additional 65 cents or 1.99% in after hours trading. by RTT Staff Writer.
and more »
Monday, September 14, 2009
Pall Q4 Earnings Top Estimate - RTT News
RTT News
RTT News
... closed Monday's regular trading session at $32.60, up 26 cents and gained an additional 65 cents or 1.99% in after hours trading. by RTT Staff Writer.
and more »
Lubrizol lifts 2009 profit outlook - Forbes
Forbes
In after-hours trading, shares of Lubrizol added $1.27 to $68.14. Shares fell 67 cents to close at $66.87 in the regular session.
and more »
AFTER THE BELL-Solutia shares rise on guidance - Interactive Investor
Interactive Investor
Interactive Investor Trading Limited, trading as "Interactive Investor", is authorised and regulated by the Financial Services Authority. ...
and more »
Genesis Lease Says It Is In Talks With Another Party On Possible ... - RTT News
RTT News
Genesis shares closed Monday's regular trading session at $7.80, up 84 cents or 12.07% and gained an additional 20 cents or 2.56% in after hours trading. by ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Dendreon Stock and Options Go Exponential (DNDN)
Dendreon Corp. (NASDAQ: DNDN) is surging on exponential volume today as traders are speculating, and hoping, that the company will become a takeover target. The word today is over hopes of a “European drug/bio/ buyer”. At 2:05 PM EST we have shares up almost 12% at $26.69 and volume is exponential at 8.8 million shares vs. average volume of 2.8 million shares. The real interest though is in the CALL options, particularly when you look at the SEPT-2009 CALL activity below. These expire this coming Friday.
Strike Volume Op.Int.
$24.00Â Â Â 3,289Â Â Â 4,477
$25.00Â Â Â 15,477Â Â Â 15,844
$26.00Â Â Â 7,338Â Â Â 4,251
$27.00Â Â Â 1,854Â Â Â 2,814
$28.00Â Â Â 1,955Â Â Â 5,963
$29.00Â Â Â 677Â Â Â 2,338
$30.00Â Â Â 4,537Â Â Â 7,709
Here is the OCT-2009 Options activity:
Strike Volume Op.Int.
$24.00Â Â Â 1,269Â Â Â 2,610
$25.00Â Â Â 1,056Â Â Â 2,156
JON C. OGG
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Expect More Upside From This Oil Refinery Firm - CNBC
CNBC
Frontier Oil ended last week at $13.40 after rising slightly Friday and inched up another nickel in after-hours trading. For the calls purchased Friday to ...
and more »
About this author: - Seeking Alpha
Seeking Alpha
... reported a loss of $12MM or $0.16/shr on Friday missing Wall St.'s expectations and sending the stock down to $43.80 or 4.1% in after hours trading. ...
and more »
Obama, Goodyear, Cooper, and China (GT, CTB)
The Obama Adminstration has levied huge import tariffs on imported Chinese tires claiming that they are exported to the US in a manner which damages the American tire industry unfairly. As we asked in the UNUSUAL SUSPECTS this weekend, “Did President Obama just say, “Blue Horseshoe loves Goodyear?”…. Goodyear Tire & Rubber Co. (NYSE: GT) is up over 6% after the open and at 9:34 AM EST we have seen 495,000 shares trade hands. Elsewhere we see that Cooper Tire & Rubber Co. (NYSE: CTB) is up over 8% at $15.80 at the same time, but that is on under 200,000 shares of stock. -JON OGG
Credit Market Overview: Sept 14, 2009 - istockAnalyst.com (press release)
istockAnalyst.com (press release)
... reported a loss of $12MM or $0.16/shr on Friday missing Wall St.'s expectations and sending the stock down to $43.80 or 4.1% in after hours trading. ...
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
BEFORE THE BELL: US Stk Futures Fall Amid Trade War Worries - Wall Street Journal
Wall Street Journal
Shares of Regeneron fell 8.6% to $20.01 in after-hours trading. Sanofi-Aventis' American depositary shares closed Friday at $35.05, up 0.4%, ...
and more »
Ariad Study Continues Ramping Shares (ARIA)
Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) is one of the top gainers this morning after announcing the result of first interim analysis of Phase 3 ‘Succeed Trial’ of Oral Ridaforolimus in metastatic sarcoma… the independent Data Monitoring Committee of the Phase 3 SUCCEED trial has completed the first interim efficacy analysis and has recommended that it continues to full patient enrollment and completion. The safety data. At 8:50 AM EST shares are up close to 16% at $3.03 on over 800,000 shares. Average volume is 2.9 million shares. -JON OGG
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Call Buyers See Frontier Oil Going Higher - TheStreet.com
TheStreet.com
Frontier Oil ended last week at $13.40 after rising slightly Friday and inched up another nickel in after-hours trading. For the calls purchased Friday to ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Patience Pays Off For Theravance - Stock To Watch - RTT News
RTT News
THRX, which has traded in the range of $4.32 - $18.56, closed Friday's trade at $18.20. In after-hours trading the stock was up 4.4% at $19. by RTT Staff ...
and more »
Sunday, September 13, 2009
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Israel stocks mixed; Teva drug advances; Ceragon jumps - MarketWatch
MarketWatch
On Friday, the company's shares traded on Wall Street jumped nearly 13% in after-hours trading. The Israeli business daily Globes speculated that the stock ...
and more »
Israel stocks mixed; Teva drug advances; Ceragon jumps - MarketWatch
MarketWatch
On Friday, the company's shares traded on Wall Street jumped nearly 13% in after-hours trading. The Israeli business daily Globes speculated that the stock ...
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Israel stocks mixed; Teva drug advances; Ceragon jumps - MarketWatch
MarketWatch
On Friday, the company's shares traded on Wall Street jumped nearly 13% in after-hours trading. The Israeli business daily Globes speculated that the stock ...
and more »
Israel stocks mixed; Teva drug advances; Ceragon jumps - MarketWatch
MarketWatch
On Friday, the company's shares traded on Wall Street jumped nearly 13% in after-hours trading. The Israeli business daily Globes speculated that the stock ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Israel stocks mixed; Teva drug advances; Ceragon jumps - MarketWatch
MarketWatch
On Friday, the company's shares traded on Wall Street jumped nearly 13% in after-hours trading. The Israeli business daily Globes speculated that the stock ...
and more »
Jim Cramer mention boosts Ceragon shares - Globes
Globes
In after-hours trading on Nasdaq the share jumped 12.5%. On the TASE the share was up 9.42% to NIS 29.50 by early afternoon trading today. ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Saturday, September 12, 2009
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Regeneron halts Phase 3 trial of cancer drug - Albany Times Union
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...
and more »
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Friday, September 11, 2009
AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...
Regeneron ends Phase 3 trial for pancreatic cancer treatment - Albany Times Union
Albany Times Union
The company announced the discontinuation of the trial after the markets closed. In after-hours trading, shares were off another 88 cents to $21.00.
and more »
Subscribe to:
Posts (Atom)
